Skip to main content
. 2021 Nov 16;8:693288. doi: 10.3389/fsurg.2021.693288

Figure 1.

Figure 1

Patient and Graft survival by EAD status. Difference in overall patient and graft survival between EAD and non-EAD groups (P = 0.092; log rank-test = 2.87; P = 0.008; log rank-test = 7.13). Levels of significance: P-values <0.05. EAD, Early allograft dysfunction; AST, Aspartate aminotransferase; INR, International normalized ratio.